Concepedia

Argun Akçakanat

AA

Statistics

Publications

41

Citations

4.1K

H-Index

31

Active since

2004

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Society of Surgical Oncology

National Cancer Institute

Harvard University

Jackson Laboratory

Argun Akçakanat is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2004–2024

41

Publications

41

PD-L1 Expression in Triple-Negative Breast Cancer

Elizabeth A. Mittendorf, Anne V. Philips, Funda Meric‐Bernstam et al. · Cancer Immunology Research · 2014 · 1.4K citations · Full text

Medicine, Molecular Biology, Oncology +17

Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation

Yan Xing, Nancy U. Lin, Matthew Maurer et al. · Breast Cancer Research · 2019 · 227 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors

Funda Meric‐Bernstam, Argun Akçakanat, Huiqin Chen et al. · Clinical Cancer Research · 2012 · 208 citations · Full text

Medicine, Oncology, Pharmacology +16

Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer

Takafumi Sangai, Argun Akçakanat, Huiqin Chen et al. · Clinical Cancer Research · 2012 · 160 citations

Medicine, Oncology, Pharmacology +17

Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

Kurt W. Evans, Erkan Yuca, Stephen M. Scott et al. · Cancer Research · 2021 · 157 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 41